塞普特纳生物 SEPN
$48.85 +$1.50 (+3.17%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $48.85 0.00%
开盘$48.20
昨收$47.35
当日区间$47.84 – $51.05
成交量384.6K
市值$2.28B
市盈率（TTM）–
股息率–
基本面
最新报告季度：Q2, ended Jun 2026
营收$26.75M+22,375.6% YoY
营业利润-$16.84M+41.9% YoY
净利润-$13.03M+47.5% YoY
摊薄每股收益-$0.29+48.2% YoY
自由现金流-$22.18M-9.0% YoY
经营现金流-$22.18M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
营业利润率-56.7%
净利率-24.5%
净资产收益率-6.3%
资产收益率-4.9%
投入资本回报率-9.0%
流动比率4.99
负债/资产比率31.8%
现金及投资$372.32M
总负债$20.14M
净现金（净负债）$352.19M
自由现金流/营收106.3%
利润表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 报告营业总收入 | $26.75M | $26.52M | $45.95M | $24.12M | $21.50M |
| 营业总收入 | $26.75M | $26.52M | $45.95M | $24.12M | $21.50M |
| 营业费用 | $43.58M | $39.82M | $126.75M | $40.14M | $31.38M |
| 销售及管理费用 | $8.45M | $10.29M | $29.16M | $8.28M | $7.12M |
| -管理费用 | $8.45M | $10.29M | $29.16M | $8.28M | $7.12M |
| 研发费用 | $35.13M | $29.54M | $97.58M | $31.86M | $24.26M |
| 营业利润 | -$16.84M | -$13.30M | -$80.80M | -$16.02M | -$9.89M |
| 非经营性利息净收入（支出） | $4.78M | $5.03M | $19.53M | $5.34M | $5.57M |
| 非经营性利息收入 | $4.78M | $5.03M | $19.53M | $5.34M | $5.57M |
| 税前利润 | -$12.06M | -$8.30M | -$48.87M | -$10.73M | $8.17M |
| 税费 | $973,000.00 | $337,000.00 | $12,000.00 | $12,000.00 | $0.00 |
| 净利润 | -$13.03M | -$8.64M | -$48.88M | -$10.74M | $8.17M |
| 持续经营利润 | -$13.03M | -$8.64M | -$48.88M | -$10.74M | $8.17M |
| 归属母公司净利润 | -$13.03M | -$8.64M | -$48.88M | -$10.74M | $8.17M |
| 归属普通股股东净利润 | -$13.03M | -$8.64M | -$48.88M | -$10.74M | $8.17M |
| 基本每股收益 | -$0.29 | -$0.19 | -$1.10 | -$0.24 | $0.18 |
| 摊薄每股收益 | -$0.29 | -$0.19 | -$1.10 | -$0.24 | $0.18 |
| 其他收入（支出） | – | -$31,000.00 | $12.40M | -$41,000.00 | $12.49M |
| 其他非经营性收入（支出） | – | -$31,000.00 | -$100,000.00 | -$41,000.00 | -$6,000.00 |
| 特殊收益（费用） | – | – | $12.50M | $0.00 | $12.50M |
| -固定资产出售收益 | – | – | $12.50M | $0.00 | $12.50M |
资产负债表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 总资产 | $566.74M | $569.69M | $596.19M | $596.19M | $606.65M |
| 流动资产合计 | $396.15M | $368.06M | $410.96M | $410.96M | $491.68M |
| 现金及现金等价物与短期投资 | $372.32M | $347.40M | $391.09M | $391.09M | $474.35M |
| -现金及现金等价物 | $84.66M | $71.61M | $120.72M | $120.72M | $319.99M |
| -短期投资 | $287.66M | $275.80M | $270.37M | $270.37M | $154.36M |
| 应收款 | $15.94M | $14.29M | $13.74M | $13.74M | $11.73M |
| -应收账款 | $12.16M | $10.84M | $10.36M | $10.36M | $8.65M |
| -应计应收利息 | $3.78M | $3.45M | $3.38M | $3.38M | $1.93M |
| 预付资产 | $7.76M | $6.26M | $4.98M | $4.98M | $5.22M |
| 其他流动资产 | $133,000.00 | $110,000.00 | $1.15M | $1.15M | $387,000.00 |
| 非流动资产合计 | $170.59M | $201.63M | $185.22M | $185.22M | $114.97M |
| 固定资产净值 | $24.26M | $25.26M | $25.93M | $25.93M | $26.35M |
| -固定资产原值 | $29.46M | $30.03M | $30.29M | $30.29M | $30.41M |
| -累计折旧 | -$5.20M | -$4.77M | -$4.35M | -$4.35M | -$4.06M |
| 投资及预付款 | $144.19M | $174.69M | $157.57M | $157.57M | $87.21M |
| -可供出售证券 | $144.19M | $174.69M | $157.57M | $157.57M | $87.21M |
| 其他非流动资产 | $2.14M | $1.68M | $1.72M | $1.72M | $1.41M |
| 负债合计 | $180.02M | $191.23M | $214.26M | $214.26M | $217.92M |
| 流动负债合计 | $79.32M | $78.17M | $86.93M | $86.93M | $75.28M |
| 应付款 | $4.76M | $7.46M | $10.28M | $10.28M | $3.73M |
| -应付账款 | $3.97M | $7.46M | $10.28M | $10.28M | $3.73M |
| -应付税款合计 | $788,000.00 | – | – | – | – |
| 一年内应计费用 | $9.02M | $5.84M | $6.09M | $6.09M | $3.58M |
| 短期债务及融资租赁负债 | $2.41M | $2.31M | $2.21M | $2.21M | $2.12M |
| -一年内到期融资租赁负债 | $2.41M | $2.31M | $2.21M | $2.21M | $2.12M |
| 一年内递延负债 | $60.35M | $59.76M | $62.27M | $62.27M | $61.60M |
| 其他流动负债 | $95,000.00 | $363,000.00 | $148,000.00 | $148,000.00 | $112,000.00 |
| 非流动负债合计 | $100.70M | $113.07M | $127.33M | $127.33M | $142.64M |
| 长期债务及融资租赁负债 | $20.14M | $20.78M | $21.41M | $21.41M | $21.99M |
| -长期融资租赁负债 | $20.14M | $20.78M | $21.41M | $21.41M | $21.99M |
| 一年以上递延负债 | $80.04M | $92.18M | $105.92M | $105.92M | $120.65M |
| 其他非流动负债 | $521,000.00 | $100,000.00 | – | – | – |
| 股东权益合计 | $386.72M | $378.46M | $381.93M | $381.93M | $388.73M |
| 股东权益 | $386.72M | $378.46M | $381.93M | $381.93M | $388.73M |
| 股本 | $46,000.00 | $45,000.00 | $45,000.00 | $45,000.00 | $45,000.00 |
| -普通股 | $46,000.00 | $45,000.00 | $45,000.00 | $45,000.00 | $45,000.00 |
| -优先股 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 资本公积 | $576.86M | $554.87M | $548.52M | $548.52M | $544.83M |
| 留存收益 | -$188.92M | -$175.89M | -$167.25M | -$167.25M | -$156.52M |
| 不影响留存收益的损益 | -$1.26M | -$569,000.00 | $617,000.00 | $617,000.00 | $375,000.00 |
| -其他应收款 | – | – | – | – | $1.15M |
现金流量表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 经营活动现金流 | -$22.18M | -$25.63M | $110.19M | -$14.99M | $168.81M |
| 持续经营经营活动现金流净额 | -$22.18M | -$25.63M | $110.19M | -$14.99M | $168.81M |
| 持续经营净利润 | -$13.03M | -$8.64M | -$48.88M | -$10.74M | $8.17M |
| 折旧、折耗与摊销 | $427,000.00 | $421,000.00 | $1.60M | $401,000.00 | $401,000.00 |
| 其他非现金项目 | -$649,000.00 | $569,000.00 | $2.16M | $569,000.00 | $2.49M |
| 营运资金变动 | -$14.75M | -$23.25M | $162.78M | -$6.99M | $170.27M |
| -应收款变动 | -$1.32M | -$486,000.00 | -$10.19M | -$1.71M | -$8.49M |
| -预付资产变动 | -$1.77M | -$294,000.00 | -$3.78M | -$825,000.00 | -$1.25M |
| -应付账款及应计费用变动 | $463,000.00 | -$5.84M | $10.96M | $10.41M | -$1.57M |
| -其他流动资产变动 | -$457,000.00 | $43,000.00 | -$554,000.00 | -$316,000.00 | -$205,000.00 |
| -其他流动负债变动 | $421,000.00 | $100,000.00 | – | – | – |
| -其他营运资金变动 | -$12.10M | -$16.77M | $166.34M | -$14.55M | $181.79M |
| 投资活动现金流净额 | $18.41M | -$23.82M | -$229.35M | -$185.30M | -$38.39M |
| 持续经营投资活动现金流净额 | $18.41M | -$23.82M | -$229.35M | -$185.30M | -$38.39M |
| 固定资产购置及出售净额 | $0.00 | -$832,000.00 | -$518,000.00 | -$65,000.00 | -$13,000.00 |
| 投资购置及出售净额 | $18.41M | -$22.99M | -$241.33M | -$185.24M | -$50.88M |
| 筹资活动现金流 | $16.82M | $333,000.00 | $1.69M | $1.02M | $263,000.00 |
| 持续经营筹资活动现金流净额 | $16.82M | $333,000.00 | $1.69M | $1.02M | $263,000.00 |
| 股票期权行使所得 | $3.04M | $333,000.00 | $1.69M | $1.02M | $264,000.00 |
| 期末现金余额 | $85.57M | $72.51M | $121.63M | $121.63M | $320.89M |
| 现金净变动 | $13.06M | -$49.12M | -$117.47M | -$199.27M | $130.68M |
| 期初现金余额 | $72.51M | $121.63M | $239.10M | $320.89M | $190.22M |
| 自由现金流 | -$22.18M | -$26.47M | $109.67M | -$15.05M | $168.79M |
| 持续经营损益 | – | – | -$12.50M | $0.00 | – |
| 递延税款 | – | – | $0.00 | $0.00 | – |
| 其他投资变动净额 | – | – | $12.50M | $0.00 | – |
| 普通股发行净额 | – | – | -$1,000.00 | $0.00 | -$1,000.00 |
| 优先股发行净额 | – | – | $0.00 | $0.00 | – |
暂无评论——快来第一个聊聊 SEPN。
登录后参与讨论。